SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Page 5 math

<< Previous

Bullboard Posts

Next >>

Comment by barryt34on Jan 28, 2021 12:15am

129 Views

Post# 32406752

RE:RE:RE:RE:RE:RE:Page 5 math

So what you are saying is that the tordx doesn't need approval because they are replacing it with a covid triage test? If that is true then it's all great. Thank you for clearing that up. I didn't read it that way. The TORdxTM LUNG Test is a breakthrough diagnostic that is expected to significantly increase the number of lung transplants for patients in the U.S. and Canada. SQI is working with U.S. and Canadian regulatory agencies to obtain regulatory approval, however submission reviews have been suspended as a result of the COVID-19 pandemic.

<< Previous

Bullboard Posts

Next >>

Get a better understanding of the psychology of options trading